{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:26:01Z","timestamp":1780500361436,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Saneron CCEL Therapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pharmaceuticals and cell-based regenerative medicine for Parkinson\u2019s disease (PD) offer palliative relief but do not arrest the disease progression. Cell therapy has emerged as an experimental treatment, but current cell sources such as human umbilical cord blood (hUCB) stem cells display only partial recapitulation of mature dopaminergic neuron phenotype and function. Nonetheless, stem cell grafts ameliorate PD-associated histological and behavioral deficits likely through stem cell graft-secreted therapeutic substances. We recently demonstrated the potential of hUCB-derived plasma in enhancing motor capabilities and gastrointestinal function, as well as preventing dopaminergic neuronal cell loss, in an 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP) rodent model of PD. Recognizing the translational need to test in another PD model, we now examined here the effects of an intravenously transplanted combination of hUCB and plasma into the 6-hydroxydopamine (6-OHDA) lesioned adult rats. Animals received three separate doses of 4\u2009\u00d7\u200910<jats:sup>6<\/jats:sup> hUCB cells with plasma beginning at 7\u00a0days after stereotaxic 6-OHDA lesion, then behaviorally and immunohistochemically evaluated over 56\u00a0days post-lesion. Whereas vehicle-treated lesioned animals exhibited the typical 6-OHDA neurobehavioral symptoms, hUCB and plasma-treated lesioned animals showed significant attenuation of motor function, gut motility, and nigral dopaminergic neuronal survival, combined with diminished pro-inflammatory microbiomes not only in the nigra, but also in the gut. Altogether these data support a regenerative medicine approach for PD by sequestering inflammation and neurotoxicity through correction of gut dysbiosis.<\/jats:p>","DOI":"10.1007\/s12015-019-09906-2","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T17:02:21Z","timestamp":1563382941000},"page":"690-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson\u2019s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity"],"prefix":"10.1007","volume":"15","author":[{"given":"Jea-Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P.","family":"Tuazon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Bonsack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Ehrhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Sanberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2966-9782","authenticated-orcid":false,"given":"Cesario V.","family":"Borlongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"key":"9906_CR1","doi-asserted-by":"publisher","unstructured":"Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A. E., & Lang, A. E. (2017). Parkinson disease. Nature Reviews. Disease Primers, 3. https:\/\/doi.org\/10.1038\/nrdp.2017.13.","DOI":"10.1038\/nrdp.2017.13"},{"key":"9906_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C., Gathagan, R. J., Covell, D. J., Medellin, C., Stieber, A., Robinson, J. L., Zhang, B., Pitkin, R. M., Olufemi, M. F., Luk, K. C., Trojanowski, J. Q., & Lee, V. M. Y. (2018). Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature, 557, 558\u2013563. https:\/\/doi.org\/10.1038\/s41586-018-0104-4.","journal-title":"Nature"},{"key":"9906_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1586\/14737175.2015.1091727","volume":"15","author":"P Pantcheva","year":"2015","unstructured":"Pantcheva, P., Reyes, S., Hoover, J., Kaelber, S., & Borlongan, C. V. (2015). Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells. Expert Review of Neurotherapeutics, 15, 1231\u20131240. https:\/\/doi.org\/10.1586\/14737175.2015.1091727.","journal-title":"Expert Review of Neurotherapeutics"},{"key":"9906_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.parkreldis.2018.07.014","volume":"57","author":"M Okazaki","year":"2018","unstructured":"Okazaki, M., Sasaki, T., Yasuhara, T., Kameda, M., Agari, T., Kin, I., Kuwahara, K., Morimoto, J., Kin, K., Umakoshi, M., Tomita, Y., Borlongan, C. V., & Date, I. (2018). Characteristics and prognostic factors of Parkinson's disease patients with abnormal postures subjected to subthalamic nucleus deep brain stimulation. Parkinsonism & Related Disorders, 57, 44\u201349. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.014.","journal-title":"Parkinsonism & Related Disorders"},{"key":"9906_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","volume":"327","author":"CR Freed","year":"1992","unstructured":"Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Kriek, E., Qi, J. X., Lone, T., Zhang, Y. B., Snyder, J. A., Wells, T. H., Ramig, L. O., Thompson, L., Mazziotta, J. C., Huang, S. C., Grafton, S. T., Brooks, D., Sawle, G., Schroter, G., & Ansari, A. A. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. The New England Journal of Medicine, 327, 1549\u20131555. https:\/\/doi.org\/10.1056\/NEJM199211263272202.","journal-title":"The New England Journal of Medicine"},{"key":"9906_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.410380307","volume":"38","author":"TB Freeman","year":"1995","unstructured":"Freeman, T. B., Olanow, C. W., Hauser, R. A., Nauert, G. M., Smith, D. A., Borlongan, C. V., Sanberg, P. R., Holt, D. A., Kordower, J. H., Vingerhoets, F. J. G., Snow, B. J., Calne, D., & Gauger, L. L. (1995). Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Annals of Neurology, 38, 379\u2013388. https:\/\/doi.org\/10.1002\/ana.410380307.","journal-title":"Annals of Neurology"},{"issue":"5","key":"9906_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ana.10359","volume":"52","author":"Y Ma","year":"2002","unstructured":"Ma, Y., Feigin, A., Dhawan, V., Fukuda, M., Shi, Q., Greene, P., Breeze, R., Fahn, S., Freed, C., & Eidelberg, D. (2002). Dyskinesia after fetal cell transplantation for parkinsonism: A PET study. Annals of Neurology, 52(5), 628\u2013634.","journal-title":"Annals of Neurology"},{"issue":"Suppl 1","key":"9906_CR8","doi-asserted-by":"publisher","first-page":"SI29","DOI":"10.1016\/S0140-6736(99)90229-5","volume":"353","author":"CV Borlongan","year":"1999","unstructured":"Borlongan, C. V., Sanberg, P. R., & Freeman, T. B. (1999). Neural transplantation for neurodegenerative disorders. Lancet, 353(Suppl 1), SI29\u2013SI30.","journal-title":"Lancet"},{"issue":"4942","key":"9906_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1126\/science.2105529","volume":"247","author":"O Lindvall","year":"1990","unstructured":"Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K., Sawle, G., Rothwell, J., & Marsden, C. (1990). Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 247(4942), 574\u2013577.","journal-title":"Science"},{"key":"9906_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJM199504273321702","volume":"332","author":"JH Kordower","year":"1995","unstructured":"Kordower, J. H., Freeman, T. B., Snow, B. J., Vingerhoets, F. J., Mufson, E. J., Sanberg, P. R., et al. (1995). Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. The New England Journal of Medicine, 332, 1118\u20131124. https:\/\/doi.org\/10.1056\/NEJM199504273321702.","journal-title":"The New England Journal of Medicine"},{"key":"9906_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nn863","volume":"5","author":"P Hagell","year":"2002","unstructured":"Hagell, P., Piccini, P., Bjorklund, A., Brundin, P., Rehncrona, S., Widner, H., et al. (2002). Dyskinesias following neural transplantation in Parkinson's disease. Nature Neuroscience, 5, 627\u2013628. https:\/\/doi.org\/10.1038\/nn863.","journal-title":"Nature Neuroscience"},{"key":"9906_CR12","doi-asserted-by":"publisher","first-page":"12497","DOI":"10.1523\/JNEUROSCI.3719-06.2006","volume":"26","author":"T Yasuhara","year":"2006","unstructured":"Yasuhara, T., Matsukawa, N., Hara, K., Yu, G., Xu, L., Maki, M., Kim, S. U., & Borlongan, C. V. (2006). Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. The Journal of Neuroscience, 26, 12497\u201312511. https:\/\/doi.org\/10.1523\/JNEUROSCI.3719-06.2006.","journal-title":"The Journal of Neuroscience"},{"key":"9906_CR13","doi-asserted-by":"publisher","first-page":"12175","DOI":"10.1073\/pnas.0704091104","volume":"104","author":"DE Redmond Jr","year":"2007","unstructured":"Redmond, D. E., Jr., Bjugstad, K. B., Teng, Y. D., Ourednik, V., Ourednik, J., Wakeman, D. R., et al. (2007). Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 12175\u201312180. https:\/\/doi.org\/10.1073\/pnas.0704091104.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9906_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pneurobio.2017.07.004","volume":"158","author":"C Stonesifer","year":"2017","unstructured":"Stonesifer, C., Corey, S., Ghanekar, S., Diamandis, Z., Acosta, S. A., & Borlongan, C. V. (2017). Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. Progress in Neurobiology, 158, 94\u2013131. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.07.004.","journal-title":"Progress in Neurobiology"},{"key":"9906_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pharmthera.2015.11.012","volume":"158","author":"S Ghaisas","year":"2016","unstructured":"Ghaisas, S., Maher, J., & Kanthasamy, A. (2016). Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacology & Therapeutics, 158, 52\u201362. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.11.012.","journal-title":"Pharmacology & Therapeutics"},{"key":"9906_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","volume":"46","author":"TG Dinan","year":"2017","unstructured":"Dinan, T. G., & Cryan, J. F. (2017). The microbiome-gut-brain Axis in health and disease. Gastroenterology Clinics of North America, 46, 77\u201389. https:\/\/doi.org\/10.1016\/j.gtc.2016.09.007.","journal-title":"Gastroenterology Clinics of North America"},{"key":"9906_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.09.032","volume":"60","author":"A Becker","year":"2018","unstructured":"Becker, A., Fassbender, K., Oertel, W. H., & Unger, M. M. (2018). A punch in the gut - intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease. Parkinsonism & Related Disorders, 60, 43\u201345. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.09.032.","journal-title":"Parkinsonism & Related Disorders"},{"key":"9906_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainres.2018.01.011","volume":"1693","author":"A Chalazonitis","year":"2018","unstructured":"Chalazonitis, A., & Rao, M. (2018). Enteric nervous system manifestations of neurodegenerative disease. Brain Research, 1693, 207\u2013213. https:\/\/doi.org\/10.1016\/j.brainres.2018.01.011.","journal-title":"Brain Research"},{"key":"9906_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/mds.27556","volume":"34","author":"DP Breen","year":"2019","unstructured":"Breen, D. P., Halliday, G. M., & Lang, A. E. (2019). Gut-brain axis and the spread of alpha-synuclein pathology: Vagal highway or dead end? Movement Disorders, 34, 307\u2013316. https:\/\/doi.org\/10.1002\/mds.27556.","journal-title":"Movement Disorders"},{"key":"9906_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","volume":"1693","author":"RA Liddle","year":"2018","unstructured":"Liddle, R. A. (2018). Parkinson's disease from the gut. Brain Research, 1693, 201\u2013206. https:\/\/doi.org\/10.1016\/j.brainres.2018.01.010.","journal-title":"Brain Research"},{"key":"9906_CR21","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.3233\/JPD-181477","volume":"8","author":"F Scheperjans","year":"2018","unstructured":"Scheperjans, F., Derkinderen, P., & Borghammer, P. (2018). The gut and Parkinson's disease: Hype or Hope? Journal of Parkinson's Disease, 8, S31\u2013S39. https:\/\/doi.org\/10.3233\/JPD-181477.","journal-title":"Journal of Parkinson's Disease"},{"key":"9906_CR22","doi-asserted-by":"publisher","unstructured":"Stolzenberg, E., Berry, D., Yang, D., Lee, E. Y., Kroemer, A., Kaufman, S., et al. (2017). A role for neuronal alpha-Synuclein in gastrointestinal immunity. Journal of Innate Immunity, 9, 456\u2013463. https:\/\/doi.org\/10.1159\/000477990.","DOI":"10.1159\/000477990"},{"key":"9906_CR23","doi-asserted-by":"publisher","unstructured":"Klingelhoefer, L., & Reichmann, H. (2017). The gut and nonmotor symptoms in Parkinson's disease. International Review of Neurobiology. https:\/\/doi.org\/10.1016\/bs.irn.2017.05.027.","DOI":"10.1016\/bs.irn.2017.05.027"},{"key":"9906_CR24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","volume":"321","author":"E Gluckman","year":"1989","unstructured":"Gluckman, E., Broxmeyer, H. A., Auerbach, A. D., Friedman, H. S., Douglas, G. W., Devergie, A., et al. (1989). Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. The New England Journal of Medicine, 321, 1174\u20131178. https:\/\/doi.org\/10.1056\/NEJM198910263211707.","journal-title":"The New England Journal of Medicine"},{"key":"9906_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbmt.2005.09.016","volume":"12","author":"PL Martin","year":"2006","unstructured":"Martin, P. L., Carter, S. L., Kernan, N. A., Sahdev, I., Wall, D., Pietryga, D., Wagner, J. E., & Kurtzberg, J. (2006). Results of the cord blood transplantation study (COBLT): Outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biology of Blood and Marrow Transplantation, 12, 184\u2013194. https:\/\/doi.org\/10.1016\/j.bbmt.2005.09.016.","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"9906_CR26","doi-asserted-by":"publisher","unstructured":"Dawson, G., Sun, J. M., Davlantis, K. S., Murias, M., Franz, L., Troy, J., et al. (2017). Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder: Results of a single-center phase I open-label trial. Stem Cells Translational Medicine. https:\/\/doi.org\/10.1002\/sctm.16-0474.","DOI":"10.1002\/sctm.16-0474"},{"key":"9906_CR27","doi-asserted-by":"publisher","unstructured":"Sun, J. M., Song, A. W., Case, L. E., Mikati, M. A., Gustafson, K. E., Simmons, R., et al. (2017). Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy: A randomized, placebo-controlled trial. Stem Cells Translational Medicine. https:\/\/doi.org\/10.1002\/sctm.17-0102.","DOI":"10.1002\/sctm.17-0102"},{"key":"9906_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/0963689717729379","volume":"27","author":"L Huang","year":"2018","unstructured":"Huang, L., Zhang, C., Gu, J., Wu, W., Shen, Z., Zhou, X., & Lu, H. (2018). A randomized, placebo-controlled trial of human umbilical cord blood mesenchymal stem cell infusion for children with cerebral palsy. Cell Transplant, 27, 325\u2013334. https:\/\/doi.org\/10.1177\/0963689717729379.","journal-title":"Cell Transplant"},{"issue":"10","key":"9906_CR29","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1161\/01.STR.0000141680.49960.d7","volume":"35","author":"CV Borlongan","year":"2004","unstructured":"Borlongan, C. V., Hadman, M., Sanberg, C. D., & Sanberg, P. R. (2004). Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke, 35(10), 2385\u20132389.","journal-title":"Stroke"},{"key":"9906_CR30","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1161\/01.STR.0000141681.06735.9b","volume":"35","author":"M Vendrame","year":"2004","unstructured":"Vendrame, M., Cassady, J., Newcomb, J., Butler, T., Pennypacker, K. R., Zigova, T., Davis Sanberg, C., Sanberg, P. R., & Willing, A. E. (2004). Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke, 35, 2390\u20132395. https:\/\/doi.org\/10.1161\/01.STR.0000141681.06735.9b.","journal-title":"Stroke"},{"key":"9906_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/scd.2008.0018","volume":"17","author":"WV Nikolic","year":"2008","unstructured":"Nikolic, W. V., Hou, H., Town, T., Zhu, Y., Giunta, B., Sanberg, C. D., Zeng, J., Luo, D., Ehrhart, J., Mori, T., Sanberg, P. R., & Tan, J. (2008). Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells and Development, 17, 423\u2013440. https:\/\/doi.org\/10.1089\/scd.2008.0018.","journal-title":"Stem Cells and Development"},{"key":"9906_CR32","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3727\/096368909X471279","volume":"18","author":"DH Park","year":"2009","unstructured":"Park, D. H., Borlongan, C. V., Willing, A. E., Eve, D. J., Cruz, L. E., Sanberg, C. D., Chung, Y. G., & Sanberg, P. R. (2009). Human umbilical cord blood cell grafts for brain ischemia. Cell Transplantation, 18, 985\u2013998. https:\/\/doi.org\/10.3727\/096368909X471279.","journal-title":"Cell Transplantation"},{"key":"9906_CR33","doi-asserted-by":"publisher","unstructured":"Giunta, B., Obregon, D., Velisetty, R., Sanberg, P. R., Borlongan, C. V., & Tan, J. (2012). The immunology of traumatic brain injury: A prime target for Alzheimer's disease prevention. Journal of Neuroinflammation, 9. https:\/\/doi.org\/10.1186\/1742-2094-9-185.","DOI":"10.1186\/1742-2094-9-185"},{"key":"9906_CR34","doi-asserted-by":"publisher","unstructured":"Zhao, J., Chen, N., Shen, N., Zhao, H., Wang, D., Shi, J., et al. (2012). Transplantation of human umbilical cord blood mesenchymal stem cells to treat a rat model of traumatic brain injury. Neural Regeneration Research. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.10.004.","DOI":"10.3969\/j.issn.1673-5374.2012.10.004"},{"key":"9906_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/scd.2012.0345","volume":"22","author":"D Darlington","year":"2013","unstructured":"Darlington, D., Deng, J., Giunta, B., Hou, H., Sanberg, C. D., Kuzmin-Nichols, N., Zhou, H. D., Mori, T., Ehrhart, J., Sanberg, P. R., & Tan, J. (2013). Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-beta-associated neuropathology in Alzheimer mice. Stem Cells and Development, 22, 412\u2013421. https:\/\/doi.org\/10.1089\/scd.2012.0345.","journal-title":"Stem Cells and Development"},{"key":"9906_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2217\/rme.14.32","volume":"9","author":"I de la Pena","year":"2014","unstructured":"de la Pena, I., Sanberg, P. R., Acosta, S., Lin, S. Z., & Borlongan, C. V. (2014). Umbilical cord blood cell and granulocyte-colony stimulating factor: Combination therapy for traumatic brain injury. Regenerative Medicine, 9, 409\u2013412. https:\/\/doi.org\/10.2217\/rme.14.32.","journal-title":"Regenerative Medicine"},{"key":"9906_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcyt.2014.08.009","volume":"17","author":"N Watson","year":"2015","unstructured":"Watson, N., Divers, R., Kedar, R., Mehindru, A., Mehindru, A., Borlongan, M. C., & Borlongan, C. V. (2015). Discarded Wharton jelly of the human umbilical cord: A viable source for mesenchymal stromal cells. Cytotherapy, 17, 18\u201324. https:\/\/doi.org\/10.1016\/j.jcyt.2014.08.009.","journal-title":"Cytotherapy"},{"issue":"2","key":"9906_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1620\/tjem.205.115","volume":"205","author":"YM Kim","year":"2005","unstructured":"Kim, Y. M., Jung, M. H., Song, H. Y., Yang, H. O., Lee, S. T., Kim, J. H., Kim, Y. T., Nam, J. H., & Mok, J. E. (2005). Ex vivo expansion of human umbilical cord blood-derived T-lymphocytes with homologous cord blood plasma. The Tohoku Journal of Experimental Medicine, 205(2), 115\u2013122.","journal-title":"The Tohoku Journal of Experimental Medicine"},{"key":"9906_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11626-010-9364-5","volume":"47","author":"JY Lee","year":"2011","unstructured":"Lee, J. Y., Nam, H., Park, Y. J., Lee, S. J., Chung, C. P., Han, S. B., & Lee, G. (2011). The effects of platelet-rich plasma derived from human umbilical cord blood on the osteogenic differentiation of human dental stem cells. In Vitro Cellular & Developmental Biology. Animal, 47, 157\u2013164. https:\/\/doi.org\/10.1007\/s11626-010-9364-5.","journal-title":"In Vitro Cellular & Developmental Biology. Animal"},{"key":"9906_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3109\/14653249.2010.548380","volume":"13","author":"L Huang","year":"2011","unstructured":"Huang, L., Critser, P. J., Grimes, B. R., & Yoder, M. C. (2011). Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cells. Cytotherapy, 13, 712\u2013721. https:\/\/doi.org\/10.3109\/14653249.2010.548380.","journal-title":"Cytotherapy"},{"key":"9906_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11626-013-9663-8","volume":"49","author":"Y Ding","year":"2013","unstructured":"Ding, Y., Yang, H., Feng, J. B., Qiu, Y., Li, D. S., & Zeng, Y. (2013). Human umbilical cord-derived MSC culture: The replacement of animal sera with human cord blood plasma. In Vitro Cellular & Developmental Biology. Animal, 49, 771\u2013777. https:\/\/doi.org\/10.1007\/s11626-013-9663-8.","journal-title":"In Vitro Cellular & Developmental Biology. Animal"},{"issue":"12","key":"9906_CR42","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1046\/j.1537-2995.2001.41121567.x","volume":"41","author":"AC Lam","year":"2001","unstructured":"Lam, A. C., Li, K., Zhang, X. B., Li, C. K., Fok, T. F., Chang, A. M., et al. (2001). Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: Duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD\/SCID mice. Transfusion, 41(12), 1567\u20131576.","journal-title":"Transfusion"},{"key":"9906_CR43","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1111\/jcmm.13898","volume":"22","author":"J Ehrhart","year":"2018","unstructured":"Ehrhart, J., Sanberg, P. R., & Garbuzova-Davis, S. (2018). Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseases. Journal of Cellular and Molecular Medicine, 22, 6157\u20136166. https:\/\/doi.org\/10.1111\/jcmm.13898.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9906_CR44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1089\/scd.2005.14.576","volume":"14","author":"MB Newman","year":"2005","unstructured":"Newman, M. B., Willing, A. E., Manresa, J. J., Davis-Sanberg, C., & Sanberg, P. R. (2005). Stroke-induced migration of human umbilical cord blood cells: Time course and cytokines. Stem Cells and Development, 14, 576\u2013586. https:\/\/doi.org\/10.1089\/scd.2005.14.576.","journal-title":"Stem Cells and Development"},{"key":"9906_CR45","doi-asserted-by":"publisher","unstructured":"Bachstetter, A. D., Pabon, M. M., Cole, M. J., Hudson, C. E., Sanberg, P. R., Willing, A. E., et al. (2008). Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neuroscience, 9. https:\/\/doi.org\/10.1186\/1471-2202-9-2.","DOI":"10.1186\/1471-2202-9-2"},{"key":"9906_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12015-010-9163-0","volume":"7","author":"DH Park","year":"2011","unstructured":"Park, D. H., Lee, J. H., Borlongan, C. V., Sanberg, P. R., Chung, Y. G., & Cho, T. H. (2011). Transplantation of umbilical cord blood stem cells for treating spinal cord injury. Stem Cell Reviews, 7, 181\u2013194. https:\/\/doi.org\/10.1007\/s12015-010-9163-0.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR47","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/0963689718766324","volume":"27","author":"HW Kim","year":"2018","unstructured":"Kim, H. W., Lee, H. S., Kang, J. M., Bae, S. H., Kim, C., Lee, S. H., Schwarz, J., Kim, G. J., Kim, J. S., Cha, D. H., Kim, J., Chang, S. W., Lee, T. H., & Moon, J. (2018). Dual effects of human placenta-derived neural cells on neuroprotection and the inhibition of neuroinflammation in a rodent model of Parkinson's disease. Cell Transplantation, 27, 814\u2013830. https:\/\/doi.org\/10.1177\/0963689718766324.","journal-title":"Cell Transplantation"},{"key":"9906_CR48","doi-asserted-by":"publisher","unstructured":"Yoo, J., Kim, H. S., Seo, J. J., Eom, J. H., Choi, S. M., Park, S., et al. (2016). Therapeutic effects of umbilical cord blood plasma in a rat model of acute ischemic stroke. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.12998.","DOI":"10.18632\/oncotarget.12998"},{"key":"9906_CR49","doi-asserted-by":"publisher","unstructured":"Lee, J. Y., Tuazon, J. P., Ehrhart, J., Sanberg, P. R., & Borlongan, C. V. (2019). Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model. Journal of Cellular and Molecular Medicine. https:\/\/doi.org\/10.1111\/jcmm.14429.","DOI":"10.1111\/jcmm.14429"},{"key":"9906_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2217\/17460751.3.3.249","volume":"3","author":"CV Borlongan","year":"2008","unstructured":"Borlongan, C. V., Chopp, M., Steinberg, G. K., Bliss, T. M., Li, Y., Lu, M., Hess, D. C., & Kondziolka, D. (2008). Potential of stem\/progenitor cells in treating stroke: The missing steps in translating cell therapy from laboratory to clinic. Regenerative Medicine, 3, 249\u2013250. https:\/\/doi.org\/10.2217\/17460751.3.3.249.","journal-title":"Regenerative Medicine"},{"key":"9906_CR51","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1161\/STROKEAHA.108.533091","volume":"40","author":"CV Borlongan","year":"2009","unstructured":"Borlongan, C. V. (2009). Cell therapy for stroke: Remaining issues to address before embarking on clinical trials. Stroke, 40, S146\u2013S148. https:\/\/doi.org\/10.1161\/STROKEAHA.108.533091.","journal-title":"Stroke"},{"key":"9906_CR52","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1099\/13500872-142-5-1097","volume":"142","author":"W Manz","year":"1996","unstructured":"Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & Schleifer, K. H. (1996). Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum Cytophaga\u2013Flavobacter\u2013Bacteroides in the natural environment. Microbiology, 142, 1097\u20131106.","journal-title":"Microbiology"},{"key":"9906_CR53","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1128\/AEM.64.9.3336-3345.1998","volume":"64","author":"AH Franks","year":"1998","unstructured":"Franks, A. H., Harmsen, H. J. M., Rangs, G. C., Jaansen, G. J., & Welling, G. W. (1998). Variations of bacterial populations in human feces quantified by fluorescent in situ hybridization with group-specific 16S rRNA-targetted oligonucleotide probes. Applied and Environmental Microbiology, 64, 3336\u20133345.","journal-title":"Applied and Environmental Microbiology"},{"key":"9906_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3402\/mehd.v11i1.7876","volume":"11","author":"HJM Harmsen","year":"1999","unstructured":"Harmsen, H. J. M., Elfferich, P., Schut, F., & Welling, G. W. (1999). A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in fecal samples by fluorescent in situ hybridization. Microbial Ecology in Health and Disease, 11, 3\u201312.","journal-title":"Microbial Ecology in Health and Disease"},{"key":"9906_CR55","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1073\/pnas.1807276115","volume":"115","author":"CV Borlongan","year":"2018","unstructured":"Borlongan, C. V. (2018). Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America, 115, 6322\u20136324. https:\/\/doi.org\/10.1073\/pnas.1807276115.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9906_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-016-0090-7","volume":"11","author":"M Pinto","year":"2016","unstructured":"Pinto, M., Nissanka, N., Peralta, S., Brambilla, R., Diaz, F., & Moraes, C. T. (2016). Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation. Molecular Neurodegeneration, 11, 25. https:\/\/doi.org\/10.1186\/s13024-016-0090-7.","journal-title":"Molecular Neurodegeneration"},{"key":"9906_CR57","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1007\/s00018-017-2549-2","volume":"74","author":"Y Shen","year":"2017","unstructured":"Shen, Y., Guo, X., Han, C., Wan, F., Ma, K., Guo, S., Wang, L., Xia, Y., Liu, L., Lin, Z., Huang, J., Xiong, N., & Wang, T. (2017). The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease. Cellular and Molecular Life Sciences, 74, 3741\u20133768. https:\/\/doi.org\/10.1007\/s00018-017-2549-2.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"9906_CR58","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1007\/s12035-018-0937-8","volume":"55","author":"P Garrido-Gil","year":"2018","unstructured":"Garrido-Gil, P., Rodriguez-Perez, A. I., Dominguez-Meijide, A., Guerra, M. J., & Labandeira-Garcia, J. L. (2018). Bidirectional neural interaction between central dopaminergic and gut lesions in Parkinson's disease models. Molecular Neurobiology, 55, 7297\u20137316. https:\/\/doi.org\/10.1007\/s12035-018-0937-8.","journal-title":"Molecular Neurobiology"},{"key":"9906_CR59","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.25882","volume":"29","author":"P Derkinderen","year":"2014","unstructured":"Derkinderen, P., Shannon, K. M., & Brundin, P. (2014). Gut feelings about smoking and coffee in Parkinson's disease. Movement Disorders, 29, 976\u2013979. https:\/\/doi.org\/10.1002\/mds.25882.","journal-title":"Movement Disorders"},{"key":"9906_CR60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J. M., Neunlist, M., & Derkinderen, P. (2013). Colonic inflammation in Parkinson's disease. Neurobiology of Disease, 50, 42\u201348. https:\/\/doi.org\/10.1016\/j.nbd.2012.09.007.","journal-title":"Neurobiology of Disease"},{"key":"9906_CR61","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., Chesselet, M. F., Keshavarzian, A., Shannon, K. M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R., & Mazmanian, S. K. (2016). Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell, 167, 1469\u20131480.e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.","journal-title":"Cell"},{"key":"9906_CR62","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/stem.1415","volume":"31","author":"M Sundberg","year":"2013","unstructured":"Sundberg, M., Bogetofte, H., Lawson, T., Jansson, J., Smith, G., Astradsson, A., Moore, M., Osborn, T., Cooper, O., Spealman, R., Hallett, P., & Isacson, O. (2013). Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells, 31, 1548\u20131562. https:\/\/doi.org\/10.1002\/stem.1415.","journal-title":"Stem Cells"},{"key":"9906_CR63","doi-asserted-by":"publisher","first-page":"20140370","DOI":"10.1098\/rstb.2014.0370","volume":"370","author":"O Lindvall","year":"2015","unstructured":"Lindvall, O. (2015). Treatment of Parkinson's disease using cell transplantation. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 370, 20140370. https:\/\/doi.org\/10.1098\/rstb.2014.0370.","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"key":"9906_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/joim.12415","volume":"279","author":"O Lindvall","year":"2016","unstructured":"Lindvall, O. (2016). Clinical translation of stem cell transplantation in Parkinson's disease. Journal of Internal Medicine, 279, 30\u201340. https:\/\/doi.org\/10.1111\/joim.12415.","journal-title":"Journal of Internal Medicine"},{"key":"9906_CR65","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1474-4422(13)70118-2","volume":"12","author":"P Calabresi","year":"2013","unstructured":"Calabresi, P., Castrioto, A., Di Filippo, M., & Picconi, B. (2013). New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. Lancet Neurology, 12, 811\u2013821. https:\/\/doi.org\/10.1016\/S1474-4422(13)70118-2.","journal-title":"Lancet Neurology"},{"key":"9906_CR66","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/brain\/aws101","volume":"135","author":"C Costa","year":"2012","unstructured":"Costa, C., Sgobio, C., Siliquini, S., Tozzi, A., Tantucci, M., Ghiglieri, V., di Filippo, M., Pendolino, V., de Iure, A., Marti, M., Morari, M., Spillantini, M. G., Latagliata, E. C., Pascucci, T., Puglisi-Allegra, S., Gardoni, F., di Luca, M., Picconi, B., & Calabresi, P. (2012). Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain, 135, 1884\u20131899. https:\/\/doi.org\/10.1093\/brain\/aws101.","journal-title":"Brain"},{"key":"9906_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1126\/science.aam6808","volume":"356","author":"T Kitamura","year":"2017","unstructured":"Kitamura, T., Ogawa, S. K., Roy, D. S., Okuyama, T., Morrissey, M. D., Smith, L. M., Redondo, R. L., & Tonegawa, S. (2017). Engrams and circuits crucial for systems consolidation of a memory. Science, 356, 73\u201378. https:\/\/doi.org\/10.1126\/science.aam6808.","journal-title":"Science"},{"key":"9906_CR68","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature13725","volume":"513","author":"RL Redondo","year":"2014","unstructured":"Redondo, R. L., Kim, J., Arons, A. L., Ramirez, S., Liu, X., & Tonegawa, S. (2014). Bidirectional switch of the valence associated with a hippocampal contextual memory engram. Nature, 513, 426\u2013430. https:\/\/doi.org\/10.1038\/nature13725.","journal-title":"Nature"},{"key":"9906_CR69","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12015-017-9798-1","volume":"14","author":"JDC Hurtado","year":"2018","unstructured":"Hurtado, J. D. C., S\u00e1nchez, J. P. B., Nunes, R. B., & de Oliveira, A. A. (2018). Stem cell transplantation and physical exercise in Parkinson's disease, a literature review of human and animal studies. Stem Cell Reviews, 14, 166\u2013176. https:\/\/doi.org\/10.1007\/s12015-017-9798-1.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12015-017-9717-5","volume":"13","author":"R Playne","year":"2017","unstructured":"Playne, R., & Connor, B. (2017). Understanding Parkinson's disease through the use of cell reprogramming. Stem Cell Reviews, 13, 151\u2013169. https:\/\/doi.org\/10.1007\/s12015-017-9717-5.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12015-015-9623-7","volume":"12","author":"SP Peng","year":"2016","unstructured":"Peng, S. P., & Copray, S. (2016). Comparison of human primary with human iPS cell-derived dopaminergic neuron grafts in the rat model for Parkinson's disease. Stem Cell Reviews, 12, 105\u2013120. https:\/\/doi.org\/10.1007\/s12015-015-9623-7.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR72","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12015-017-9739-z","volume":"13","author":"GS Park","year":"2017","unstructured":"Park, G. S., Park, M. H., Shin, W., Zhao, C., Sheikh, S., Oh, S. J., & Kim, H. J. (2017). Emulating host-microbiome ecosystem of human gastrointestinal tract in vitro. Stem Cell Reviews, 13, 321\u2013334. https:\/\/doi.org\/10.1007\/s12015-017-9739-z.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR73","doi-asserted-by":"publisher","unstructured":"Napoli, E., & Borlongan, C. V. (2017). Stem cell recipes of bone marrow and fish: Just what the stroke doctors ordered. Stem Cell Reviews. https:\/\/doi.org\/10.1007\/s12015-016-9716-y.","DOI":"10.1007\/s12015-016-9716-y"},{"key":"9906_CR74","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12015-019-9873-x","volume":"15","author":"SA Acosta","year":"2019","unstructured":"Acosta, S. A., Lee, J. Y., Nguyen, H., Kaneko, Y., & Borlongan, C. V. (2019). Endothelial progenitor cells modulate inflammation-associated stroke Vasculome. Stem Cell Reviews, 15, 256\u2013275. https:\/\/doi.org\/10.1007\/s12015-019-9873-x.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR75","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12015-018-9843-8","volume":"14","author":"V Holan","year":"2018","unstructured":"Holan, V., Cechova, K., Zajicova, A., Kossl, J., Hermankova, B., Bohacova, P., Hajkova, M., Krulova, M., Svoboda, P., & Javorkova, E. (2018). The impact of morphine on the characteristics and function properties of human mesenchymal stem cells. Stem Cell Reviews, 14, 801\u2013811. https:\/\/doi.org\/10.1007\/s12015-018-9843-8.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR76","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12015-018-9837-6","volume":"14","author":"D Bhartiya","year":"2018","unstructured":"Bhartiya, D. (2018). Will iPS cells regenerate or just provide trophic support to the diseased tissues? Stem Cell Reviews, 14, 629\u2013631. https:\/\/doi.org\/10.1007\/s12015-018-9837-6.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR77","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12015-018-9834-9","volume":"14","author":"CA Cismaru","year":"2018","unstructured":"Cismaru, C. A., Pop, L., & Berindan-Neagoe, I. (2018). Incognito: Are microchimeric fetal stem cells that cross placental barrier real emissaries of peace? Stem Cell Reviews, 14, 632\u2013641. https:\/\/doi.org\/10.1007\/s12015-018-9834-9.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR78","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s12015-018-9825-x","volume":"14","author":"D Hielscher","year":"2018","unstructured":"Hielscher, D., Kaebisch, C., Braun, B. J. V., Gray, K., & Tobiasch, E. (2018). Stem cell sources and graft material for vascular tissue engineering. Stem Cell Reviews, 14, 642\u2013667. https:\/\/doi.org\/10.1007\/s12015-018-9825-x.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR79","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s12015-018-9824-y","volume":"14","author":"A Ghaderi","year":"2018","unstructured":"Ghaderi, A., & Abtahi, S. (2018). Mesenchymal stem cells: Miraculous healers or dormant killers? Stem Cell Reviews, 14, 722\u2013733. https:\/\/doi.org\/10.1007\/s12015-018-9824-y.","journal-title":"Stem Cell Reviews"},{"key":"9906_CR80","doi-asserted-by":"publisher","unstructured":"Abbasi-Malati, Z., Roushandeh, A. M., Kuwahara, Y., & Roudkenar, M. H. (2018). Mesenchymal stem cells on horizon: A new arsenal of therapeutic agents. Stem Cell Reviews. https:\/\/doi.org\/10.1007\/s12015-018-9817-x.","DOI":"10.1007\/s12015-018-9817-x"},{"issue":"4","key":"9906_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/01616412.1996.11740425","volume":"18","author":"CV Borlongan","year":"1996","unstructured":"Borlongan, C. V., Stahl, C. E., Cameron, D. F., Saporta, S., Freeman, T. B., Cahill, D. W., & Sanberg, P. R. (1996). CNS immunological modulation of neural graft rejection and survival. Neurological Research, 18(4), 297\u2013304.","journal-title":"Neurological Research"}],"updated-by":[{"DOI":"10.1007\/s12015-022-10396-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000}}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-019-09906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-019-09906-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-019-09906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T18:41:36Z","timestamp":1654713696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-019-09906-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["9906"],"URL":"https:\/\/doi.org\/10.1007\/s12015-019-09906-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12015-022-10396-y","asserted-by":"object"}]},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,17]]},"assertion":[{"value":"17 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12015-022-10396-y","URL":"https:\/\/doi.org\/10.1007\/s12015-022-10396-y","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"P.R.S. is a co-founder for Saneron CCEL Therapeutics, Inc. J.E. is the Director of Research and Development for Saneron CCEL Therapeutics, Inc. P.R.S. and C.V.B. have patents for the application of hUCB as a cell therapy for several disorders. J.Y.L., J.P.T., S.C., B.B., and S.A., have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human tissue were in accordance with the ethical standards of the Institutional Research Board at the University of South Florida (USF) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Saneron CCEL Therapeutics obtain approval under USF IRB# 131111. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the University of South Florida Institutional Animal Care and Use Committee under permit number: IS00003373.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}